BodaBody, Inc. – Trademark Portfolio

Entity Type: 03

BodaBody, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RE-REZZED. The owner is based in San Francisco, CA.

60 Allen Street

San Francisco, CA 94109

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RE-REZZED
RE-REZZED
Registered 2020
REZ BAR
REZ BAR
Abandoned 2020

Trademark Classifications

BodaBody, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BodaBody, Inc. have?

BodaBody, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does BodaBody, Inc. file in?

BodaBody, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 5 (Pharmaceuticals). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.

What are BodaBody, Inc.'s most well-known trademarks?

BodaBody, Inc.'s registered trademark portfolio includes well-known marks such as RE-REZZED. These are among 1 currently registered trademark in the portfolio.

What is BodaBody, Inc.'s trademark registration success rate?

BodaBody, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.